Compare WFCF & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WFCF | INMB |
|---|---|---|
| Founded | 1996 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.1M | 49.2M |
| IPO Year | 2011 | 2019 |
| Metric | WFCF | INMB |
|---|---|---|
| Price | $12.83 | $2.25 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $4.30 |
| AVG Volume (30 Days) | 3.8K | ★ 480.6K |
| Earning Date | 11-13-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 45.82 | N/A |
| EPS | ★ 0.53 | N/A |
| Revenue | ★ $25,512,000.00 | $50,000.00 |
| Revenue This Year | N/A | $173.21 |
| Revenue Next Year | N/A | $12,733.99 |
| P/E Ratio | $24.90 | ★ N/A |
| Revenue Growth | N/A | ★ 19.05 |
| 52 Week Low | $9.26 | $1.38 |
| 52 Week High | $13.78 | $11.64 |
| Indicator | WFCF | INMB |
|---|---|---|
| Relative Strength Index (RSI) | 63.28 | 74.00 |
| Support Level | $12.50 | $1.54 |
| Resistance Level | $13.15 | $2.26 |
| Average True Range (ATR) | 0.41 | 0.15 |
| MACD | 0.15 | 0.09 |
| Stochastic Oscillator | 100.00 | 97.53 |
Where Food Comes From Inc is a third-party food verification company. It offers food production audits and uses verification processes to ensure that claims made by food producers and processors are accurate. The company supports farmers, ranchers, vineyards, wineries, processors, retailers, distributors, trade associations, and restaurants with a wide variety of value-added services provided through its family of verifiers, including International Certification Services, Validus Verification Services, and others. The company operates in two segments that are verification and certification and Software Sales and Related Consulting. It generates the majority of its revenue from verification and certification.
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.